CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Shift from volume- to value-based care
4.1.2. Rising geriatric population and the subsequent increase in the prevalence of chronic
diseases.
4.1.3. Delays in drug development and the subsequent increase in development costs
4.2. Market Restraints & Challenges
4.2.1. Lack of universally accepted methodological standards and data processing
infrastructure
4.2.2. Reluctance to rely on real-world studies
4.3. Market Opportunities
4.3.1. Growth opportunities in emerging markets
4.3.2. Rising focus on end-to-end services
CHAPTER 5. GLOBAL PORTABLE ULTRASOUND MARKET – BY COMPONENT
5.1. Data Sets
5.1.1 Clinical Settings Data
5.1.2 Claims Data
5.1.3 Pharmacy Data
5.1.4 Patient-Powered Data
5.2 Services
CHAPTER 6. GLOBAL PORTABLE ULTRASOUND MARKET – BY THERAPEUTIC
AREA
6.1. Oncology
6.2. Cardiovascular disease
6.3. Neurology
6.4. Immunology
6.5. Other therapeutic areas
CHAPTER 7. GLOBAL PORTABLE ULTRASOUND MARKET – BY END USER
7.1. Pharmaceutical & medical device companies
7.2. Healthcare Payers
7.3. Healthcare providers
7.4. Other end users
CHAPTER 8. GLOBAL PORTABLE ULTRASOUND MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL PORTABLE ULTRASOUND MARKET - COMPANY
PROFILES
9.1. PerkinElmer
9.2. Icon Plc
9.3. Oracle
9.4. Cognizant
9.5. Syneos Health
9.6. Anthem
9.7. Clinigen
9.8. SAS Institute
9.9. IQVIA
9.10. IBM
9.11. Pharmaceutical Product Development
9.12. Paraexel
9.13. Optum, Inc.
CHAPTER 10. GLOBAL PORTABLE ULTRASOUND MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
